BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 28860738)

  • 21. Changes in respiratory function impairment following the treatment of severe pulmonary tuberculosis - limitations for the underlying COPD detection.
    Radovic M; Ristic L; Ciric Z; Dinic-Radovic V; Stankovic I; Pejcic T; Rancic M; Bogdanovic D
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1307-16. PubMed ID: 27366058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Pulmonary Arterial Hypertension in Chronic Obstructive Lung Disease from Three-Dimensional Vectorcardiographic Parameters.
    Pan D; Liu R; Ren S; Li C; Chang Q
    Ann Noninvasive Electrocardiol; 2016 May; 21(3):280-6. PubMed ID: 26414072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compartment-specific remodeling patterns in end-stage chronic obstructive pulmonary disease with and without severe pulmonary hypertension.
    Zeder K; Marsh LM; Avian A; Brcic L; Birnhuber A; Douschan P; Foris V; Sassmann T; Hoetzenecker K; Boehm PM; Kwapiszewska G; Olschewski A; Olschewski H; Kovacs G
    J Heart Lung Transplant; 2024 Jul; 43(7):1090-1101. PubMed ID: 38382583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Respiratory variation in superior vena cava flow in patients with chronic obstructive pulmonary disease: estimation of pulmonary hypertension using Doppler flow index.
    Kunichika N; Miyahara N; Harada M; Tanimoto M
    J Am Soc Echocardiogr; 2002 Oct; 15(10 Pt 2):1165-9. PubMed ID: 12411900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease.
    Stone AC; Machan JT; Mazer J; Casserly B; Klinger JR
    Lung; 2011 Jun; 189(3):207-12. PubMed ID: 21556789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD.
    Higham MA; Dawson D; Joshi J; Nihoyannopoulos P; Morrell NW
    Eur Respir J; 2001 Mar; 17(3):350-5. PubMed ID: 11405510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the value of right heart echocardiographic metrics for detection of pulmonary hypertension in patients with advanced lung disease.
    Amsallem M; Boulate D; Kooreman Z; Zamanian RT; Fadel G; Schnittger I; Fadel E; McConnell MV; Dhillon G; Mercier O; Haddad F
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):825-835. PubMed ID: 28120156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung function in patients with chronic airflow obstruction due to tuberculous destroyed lung.
    Lee JH; Chang JH
    Respir Med; 2003 Nov; 97(11):1237-42. PubMed ID: 14635980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary function abnormalities in adult patients with acute exacerbation of bronchiectasis: A retrospective risk factor analysis.
    Ma Y; Niu Y; Tian G; Wei J; Gao Z
    Chron Respir Dis; 2015 Aug; 12(3):222-9. PubMed ID: 25882894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Right atrial strain is predictive of clinical outcomes and invasive hemodynamic data in group 1 pulmonary arterial hypertension.
    Bhave NM; Visovatti SH; Kulick B; Kolias TJ; McLaughlin VV
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):847-855. PubMed ID: 28168563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. History of pulmonary tuberculosis affects the severity and clinical outcomes of COPD.
    Park HJ; Byun MK; Kim HJ; Ahn CM; Kim DK; Kim YI; Oh JY; Yoon HK; Yoo KH; Jung KS
    Respirology; 2018 Jan; 23(1):100-106. PubMed ID: 28845558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of clinical characteristics of different types of lung function impaiement in TDL patients.
    Zhao J; Cao X; Li Y; Li Y; Ma T; Liu F; Ruan H
    BMC Pulm Med; 2024 Jun; 24(1):292. PubMed ID: 38914991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of Chronic Obstructive Pulmonary Disease Patients with Pulmonary Hypertension Assessed by Echocardiography in a Three-Year Observational Cohort Study.
    Nakayama S; Chubachi S; Sakurai K; Irie H; Tsutsumi A; Hashiguchi M; Itabashi Y; Murata M; Nakamura H; Asano K; Fukunaga K
    Int J Chron Obstruct Pulmon Dis; 2020; 15():487-499. PubMed ID: 32184586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical characteristics of patients with tuberculosis-destroyed lung.
    Rhee CK; Yoo KH; Lee JH; Park MJ; Kim WJ; Park YB; Hwang YI; Kim YS; Jung JY; Moon JY; Rhee YK; Park HK; Lim JH; Park HY; Lee SW; Kim YH; Lee SH; Yoon HK; Kim JW; Kim JS; Kim YK; Oh YM; Lee SD; Kim HJ
    Int J Tuberc Lung Dis; 2013 Jan; 17(1):67-75. PubMed ID: 23232006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased plasma levels of adrenomedullin, a vasoactive peptide, in patients with end-stage pulmonary disease.
    Vizza CD; Letizia C; Sciomer S; Naeije R; Della Rocca G; Di Roma A; Musarò S; Quattrucci S; Gaudio C; Battagliese A; Badagliacca R; D'Erasmo E; Fedele F
    Regul Pept; 2005 Jan; 124(1-3):187-93. PubMed ID: 15544858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pulmonary hypertension in patients with chronic obstructive pulmonary disease: clinical characteristics and risk factors].
    Wang T; Mao Y; Sun Y; Hou W; Feng Y; Qu H
    Zhonghua Nei Ke Za Zhi; 2015 Dec; 54(12):1037-40. PubMed ID: 26887371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.